Establishment Labs Inc (ESTA) Enterprise Value to EBITDA Ratio
Establishment Labs operates sterile manufacturing plants in Costa Rica, ensuring consistent quality for its silicone implants. This EV/EBITDA multiple chart visualizes the market valuation of assets, where the 0.00 level represents the current value. Global growth in demand for innovation is expanding the brand's presence in Asia and the US, although reliance on discretionary spending leaves revenue vulnerable during economic downturns.
Comprehensive metric breakdowns and analytics for establishmentlabs.com (ESTA)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Establishment Labs|ESTA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Establishment Labs Holdings Inc.|ESTA - Company Total Debt|Debts to Book Capitalization Establishment Labs Inc|ESTA - Long-Term Debt|Company Short-Term Debts Establishment Labs|Quick Ratio establishmentlabs.com
- financial results and valuation multiples details:
ESTA - Net Financial Result|Projected Future Earnings Establishment Labs|ESTA - Price to Earnings Ratio|Forward P/E Multiple Establishment Labs|ESTA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Establishment Labs Inc|ESTA - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Establishment Labs|ESTA - Earnings per share for the trailing year|Quarterly EPS earnings growth establishmentlabs.com|ESTA - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Establishment Labs
Analysis of all company metrics:Motiva ESTA
Patent protection for Motiva implants creates high market value for Establishment Labs (ESTA), making EV/EBITDA analysis key to evaluating the effectiveness of this technological advantage. The company's EV/EBITDA ratio reflects the total enterprise value, including debt, relative to operating profit, allowing investors to determine the asset's degree of undervaluation relative to the industry and identify an entry point amid stable cash flow.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA iLet Bionic Pancreas|IRMD: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation EMBC|TNDM (Tandem Diabetes Care, Inc.) - EV/EBITDA Multiple|AxoGen Inc (AXGN) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SIBN|Enterprise Value to EBITDA Ratio Orthofix Corp OFIX|EV/EBITDA Multiple BVS (Bioventus Inc.)|EV/EBITDA Multiple OrthoPediatrics Corp KIDS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|Company Value to EBITDA Autonomix Medical (AMIX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Bone Biologics Corp. (BBLG) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|Enterprise Value to Operating Income Before Depreciation Ratio BIOL|EV/EBITDA Multiple DYNT (Dynatronics)|EV/EBITDA Multiple Paragon 28 Inc. FNA|INVO Bio - EV/EBITDA Multiple
